| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular and Cell Genetics, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Tottori 683, Japan [M. S., M. O.]; Department of Reproductive Physiology and Endocrinology, Medical Institute of Bioregulation, Kyushu University, Beppu, Oita 874, Japan [T. H., N. W.]; Department of Obstetrics and Gynecology, Hokkaido University, School of Medicine, Kitaku, Sapporo 060, Japan [H. Y.]; and Laboratory of Molecular Carcinogenesis, Environmental Carcinogenesis Program, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709 [J. C. B.]
Normal cells in culture generally senesce whereas tumor-derived cells are often, but not without exception, immortal and grow indefinitely. For cells to escape the senescence program, normal genes must be lost or inactivated as shown by somatic cell genetic studies. For example, the introduction of specific chromosomes by microcell-mediated chromosome transfer has been shown to induce senescence of human and rodent tumor cell lines, and the mapping of over ten senescence genes has been achieved by this method. In this study, we observed that two different normal chromosomes induce senescence in the same human endometrial carcinoma cell line, which suggests that multiple pathways to senescence are inactivated in this cell line. This hypothesis has implications for the mechanisms of cellular senescence and its role in carcinogenesis. Furthermore, this hypothesis can explain why not all tumor-derived cells are immortal.
1 Present address: Department of Reproductive Physiology and Endocrinology, Medical Institute of Bioregulation, Kyushu University, Beppu, Oita, 874, Japan.
2 To whom requests for reprints should be addressed.
Received 8/ 8/94. Accepted 10/19/94.
This article has been cited by other articles:
![]() |
N. Zhao, G. Huang, L. Guo, and S.-H. Lu ECRG1, a Novel Candidate of Tumor Suppressor Gene in the Esophageal Carcinoma, Triggers a Senescent Program in NIH3T3 Cells Experimental Biology and Medicine, January 1, 2006; 231(1): 84 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Schwarze, S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. F. Jarrard Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells J. Biol. Chem., April 19, 2002; 277(17): 14877 - 14883. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poignee, C. Backsch, K. Beer, L. Jansen, N. Wagenbach, E. J. Stanbridge, R. Kirchmayr, A. Schneider, and M. Durst Evidence for a Putative Senescence Gene Locus within the Chromosomal Region 10p14-p15 Cancer Res., October 1, 2001; 61(19): 7118 - 7121. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Frosina Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes Carcinogenesis, September 1, 2001; 22(9): 1335 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Reddel The role of senescence and immortalization in carcinogenesis Carcinogenesis, March 1, 2000; 21(3): 477 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Solinas-Toldo, M. Durst, and P. Lichter Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality PNAS, April 15, 1997; 94(8): 3854 - 3859. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |